Who owns 04611X101 - INTRA CELLULAR THERAPIES INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

INTRA CELLULAR THERAPIES INC - COM Institutional Ownership

Q: What is CUSIP 04611X101?

CUSIP 04611X101 is the security identifier used in SEC filing datasets for 04611X101 - INTRA CELLULAR THERAPIES INC - COM.

CUSIP: 04611X101

13F Institutional Holders and Ownership History from Q2 2017 to Q3 2017

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 04611X101?
CUSIP 04611X101 identifies 04611X101 - INTRA CELLULAR THERAPIES INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 04611X101:

Q3 2017 (0 holders) Q2 2017 (1 holder)

Institutional Holders of INTRA CELLULAR THERAPIES INC - COM across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2017 Q3	0	$0	-$1,056,000				0
2017 Q2	85,000	$1,056,000	+$1,056,000			$12.42	1